Sean Senn - 14 Jul 2022 Form 4/A - Amendment Insider Report for Immix Biopharma, Inc. (IMMX)

Role
Under 10% owner
Signature
/s/ Ilya Rachman as Attorney-in-Fact for Sean Senn
Issuer symbol
IMMX
Transactions as of
14 Jul 2022
Net transactions value
-$550
Form type
4/A - Amendment
Filing time
22 Jul 2022, 16:12:46 UTC
Date Of Original Report
18 Jul 2022
Previous filing
18 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IMMX Common Stock Sale $550 -200 -0.02% $2.75 899,800 14 Jul 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Sean Senn is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.